speb/financial-data huggingface dataset:
BIOX balance_sheet (annual, 2022-06-30) — Other Current Borrowings: 71301468.00
BIOX balance_sheet (annual, 2022-06-30) — Other Current Liabilities: 3048562.00
BIOX balance_sheet (annual, 2022-06-30) — Other Equity Interest: 3943670.00
BIOX income_statement (annual, 2022-06-30) — Other Gand A: 17005842.00
BIOX income_statement (annual, 2022-06-30) — Other Income Expense: -12229783.00
BIOX balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 76704869.00
BIOX balance_sheet (annual, 2022-06-30) — Other Inventories: 57313.00
BIOX cash_flow (annual, 2022-06-30) — Other Non Cash Items: 20432328.00
BIOX balance_sheet (annual, 2022-06-30) — Other Non Current Liabilities: 9854228.00
BIOX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: -3896060.00
BIOX income_statement (annual, 2022-06-30) — Other Operating Expenses: 883267.00
BIOX balance_sheet (annual, 2022-06-30) — Other Payable: 133198.00
BIOX balance_sheet (annual, 2022-06-30) — Other Properties: 12144026.00
BIOX balance_sheet (annual, 2022-06-30) — Other Receivables: 2388830.00
BIOX balance_sheet (annual, 2022-06-30) — Other Short Term Investments: 5136010.00
BIOX income_statement (annual, 2022-06-30) — Other Special Charges: -1646774.00
BIOX income_statement (annual, 2022-06-30) — Other Taxes: 10671564.00
BIOX balance_sheet (annual, 2022-06-30) — Payables: 133388384.00
BIOX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 133388384.00
BIOX balance_sheet (annual, 2022-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 7619121.00
BIOX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 4648164.00
BIOX income_statement (annual, 2022-06-30) — Pretax Income: 14063630.00
BIOX cash_flow (annual, 2022-06-30) — Proceeds From Stock Option Exercised: 0.00
BIOX balance_sheet (annual, 2022-06-30) — Properties: 40659129.00
BIOX cash_flow (annual, 2022-06-30) — Provisionand Write Offof Assets: 2740415.00
BIOX cash_flow (annual, 2022-06-30) — Purchase Of Business: 0.00
BIOX cash_flow (annual, 2022-06-30) — Purchase Of Intangibles: -389039.00
BIOX cash_flow (annual, 2022-06-30) — Purchase Of Investment: -2055878.00
BIOX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -3458790.00
BIOX balance_sheet (annual, 2022-06-30) — Raw Materials: 18718349.00
BIOX balance_sheet (annual, 2022-06-30) — Receivables: 128079128.00
BIOX income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 199186740.00
BIOX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 9187935.00
BIOX cash_flow (annual, 2022-06-30) — Repayment Of Debt: -111692874.00
BIOX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: 0.00
BIOX income_statement (annual, 2022-06-30) — Research And Development: 6947460.00
BIOX balance_sheet (annual, 2022-06-30) — Restricted Cash: 265123.00
BIOX balance_sheet (annual, 2022-06-30) — Retained Earnings: -32682893.00
BIOX income_statement (annual, 2022-06-30) — Salaries And Wages: 24362794.00
BIOX cash_flow (annual, 2022-06-30) — Sale Of Business: 0.00
BIOX cash_flow (annual, 2022-06-30) — Sale Of Investment: 12331390.00
BIOX cash_flow (annual, 2022-06-30) — Sale Of PPE: 2046771.00
BIOX income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 14369417.00
BIOX income_statement (annual, 2022-06-30) — Selling General And Administration: 57359012.00
BIOX balance_sheet (annual, 2022-06-30) — Share Issued: 45870346.00
BIOX cash_flow (annual, 2022-06-30) — Short Term Debt Payments: -32838.00
BIOX income_statement (annual, 2022-06-30) — Special Income Charges: 48732.00
BIOX cash_flow (annual, 2022-06-30) — Stock Based Compensation: 1430745.00
BIOX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 127614466.00
BIOX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 14835912.00
BIOX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: -3317349.35
BIOX income_statement (annual, 2022-06-30) — Tax Provision: 17972534.00
BIOX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.35
BIOX balance_sheet (annual, 2022-06-30) — Taxes Receivable: 10719041.00
BIOX cash_flow (annual, 2022-06-30) — Taxes Refund Paid: -7059177.00
BIOX balance_sheet (annual, 2022-06-30) — Total Assets: 518220361.00
BIOX balance_sheet (annual, 2022-06-30) — Total Capitalization: 214350706.00
BIOX balance_sheet (annual, 2022-06-30) — Total Debt: 169788992.00
BIOX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 158298848.00
BIOX income_statement (annual, 2022-06-30) — Total Expenses: 284235978.00
BIOX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 359921513.00
BIOX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 220515235.00
BIOX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 137255761.00
BIOX income_statement (annual, 2022-06-30) — Total Operating Income As Reported: 39869926.00
BIOX income_statement (annual, 2022-06-30) — Total Other Finance Cost: 2973207.00
BIOX balance_sheet (annual, 2022-06-30) — Total Tax Payable: 8804535.00
BIOX income_statement (annual, 2022-06-30) — Total Unusual Items: -9478141.00
BIOX income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: -9478141.00
BIOX balance_sheet (annual, 2022-06-30) — Tradeand Other Payables Non Current: 0.00
BIOX balance_sheet (annual, 2022-06-30) — Treasury Stock: 3530926.00
BIOX balance_sheet (annual, 2022-06-30) — Working Capital: 75039374.00
BIOX income_statement (annual, 2022-06-30) — Write Off: 1598042.00
BIOX income_statement (annual, 2023-06-30) — +Operating Expense: 125623927.00
BIOX income_statement (annual, 2023-06-30) — +Total Revenue: 419446439.00
BIOX balance_sheet (annual, 2023-06-30) — Accounts Payable: 146258023.00
BIOX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 158006474.00
BIOX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -7226617.00
BIOX balance_sheet (annual, 2023-06-30) — Additional Paid In Capital: 326247718.00
BIOX balance_sheet (annual, 2023-06-30) — Allowance For Doubtful Accounts Receivable: -11119623.00
BIOX income_statement (annual, 2023-06-30) — Amortization: 6013633.00
BIOX cash_flow (annual, 2023-06-30) — Amortization Cash Flow: 10991433.00
BIOX cash_flow (annual, 2023-06-30) — Amortization Of Intangibles: 10991433.00
BIOX income_statement (annual, 2023-06-30) — Amortization Of Intangibles Income Statement: 6013633.00
BIOX balance_sheet (annual, 2023-06-30) — Available For Sale Securities: 444909.00
BIOX income_statement (annual, 2023-06-30) — Basic Average Shares: 62146082.00
BIOX income_statement (annual, 2023-06-30) — Basic EPS: 0.30
BIOX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 33475266.00
BIOX cash_flow (annual, 2023-06-30) — Capital Expenditure: -22563189.00
BIOX cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -10753047.00
BIOX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 13889223.00
BIOX balance_sheet (annual, 2023-06-30) — Capital Stock: 6493.00
BIOX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 48129194.00
BIOX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 60051511.00
BIOX cash_flow (annual, 2023-06-30) — Cash Dividends Paid: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Cash Equivalents: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Cash Financial: 48129194.00
BIOX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 32954000.00
BIOX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -25725670.00
BIOX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Operating Activities: 2588792.00
BIOX cash_flow (annual, 2023-06-30) — Change In Account Payable: -4501398.00
BIOX cash_flow (annual, 2023-06-30) — Change In Income Tax Payable: -16154083.00
BIOX cash_flow (annual, 2023-06-30) — Change In Inventory: -11066489.00
BIOX cash_flow (annual, 2023-06-30) — Change In Other Current Liabilities: 0.00
BIOX cash_flow (annual, 2023-06-30) — Change In Other Working Capital: -1196044.00
BIOX cash_flow (annual, 2023-06-30) — Change In Payable: -4501398.00
BIOX cash_flow (annual, 2023-06-30) — Change In Payables And Accrued Expense: -4501398.00
BIOX cash_flow (annual, 2023-06-30) — Change In Receivables: -68342840.00
BIOX cash_flow (annual, 2023-06-30) — Change In Tax Payable: -16154083.00
BIOX cash_flow (annual, 2023-06-30) — Change In Working Capital: -85106771.00
BIOX cash_flow (annual, 2023-06-30) — Changes In Account Receivables: -56867123.00
BIOX cash_flow (annual, 2023-06-30) — Changes In Cash: 9817122.00
BIOX balance_sheet (annual, 2023-06-30) — Common Stock: 6493.00
BIOX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 298849981.00
BIOX cash_flow (annual, 2023-06-30) — Common Stock Payments: -2996947.00
BIOX balance_sheet (annual, 2023-06-30) — Construction In Progress: 11911194.00
BIOX income_statement (annual, 2023-06-30) — Cost Of Revenue: 240594682.00
BIOX balance_sheet (annual, 2023-06-30) — Current Assets: 397114401.00
BIOX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 3858699.00
BIOX balance_sheet (annual, 2023-06-30) — Current Debt: 107639659.00
BIOX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 111498358.00
BIOX balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 24875662.00
BIOX balance_sheet (annual, 2023-06-30) — Current Deferred Revenue: 24875662.00
BIOX balance_sheet (annual, 2023-06-30) — Current Liabilities: 298712534.00
BIOX cash_flow (annual, 2023-06-30) — Deferred Income Tax: -1068652.00
BIOX cash_flow (annual, 2023-06-30) — Deferred Tax: -1068652.00
BIOX cash_flow (annual, 2023-06-30) — Depreciation: 8399168.00
BIOX cash_flow (annual, 2023-06-30) — Depreciation Amortization Depletion: 19390601.00
BIOX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 11136935.00
BIOX cash_flow (annual, 2023-06-30) — Depreciation And Amortization: 19390601.00
BIOX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 11136935.00
BIOX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 5123302.00
BIOX income_statement (annual, 2023-06-30) — Diluted Average Shares: 63185508.00
BIOX income_statement (annual, 2023-06-30) — Diluted EPS: 0.30
BIOX income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: 18779876.00
BIOX balance_sheet (annual, 2023-06-30) — Duefrom Related Parties Current: 9896648.00
BIOX balance_sheet (annual, 2023-06-30) — Duefrom Related Parties Non Current: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Dueto Related Parties Current: 35292.00
BIOX balance_sheet (annual, 2023-06-30) — Dueto Related Parties Non Current: 622823.00
BIOX income_statement (annual, 2023-06-30) — EBIT: 40335690.00
BIOX income_statement (annual, 2023-06-30) — EBITDA: 59726291.00
BIOX income_statement (annual, 2023-06-30) — Earnings From Equity Interest: 1198628.00
BIOX cash_flow (annual, 2023-06-30) — Earnings Losses From Equity Investments: -1065549.00
BIOX cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: 4938573.00
BIOX cash_flow (annual, 2023-06-30) — End Cash Position: 48129194.00
BIOX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 32954000.00
BIOX balance_sheet (annual, 2023-06-30) — Finished Goods: 116484128.00
BIOX balance_sheet (annual, 2023-06-30) — Fixed Assets Revaluation Reserve: -160702.00
BIOX balance_sheet (annual, 2023-06-30) — Foreign Currency Translation Adjustments: 1282377.00
BIOX cash_flow (annual, 2023-06-30) — Free Cash Flow: -19974397.00
BIOX cash_flow (annual, 2023-06-30) — Gain Loss On Sale Of PPE: -74593.00
BIOX income_statement (annual, 2023-06-30) — Gain On Sale Of Ppe: 0.00
BIOX income_statement (annual, 2023-06-30) — Gain On Sale Of Security: -11728435.00
BIOX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 1121675.00
BIOX income_statement (annual, 2023-06-30) — General And Administrative Expense: 70226083.00
BIOX balance_sheet (annual, 2023-06-30) — Goodwill: 112163432.00
BIOX balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 285947388.00
BIOX balance_sheet (annual, 2023-06-30) — Gross Accounts Receivable: 169126097.00
BIOX balance_sheet (annual, 2023-06-30) — Gross PPE: 89017027.00
BIOX income_statement (annual, 2023-06-30) — Gross Profit: 178851757.00
BIOX balance_sheet (annual, 2023-06-30) — Income Tax Payable: 509034.00
BIOX income_statement (annual, 2023-06-30) — Insurance And Claims: 3006387.00
BIOX income_statement (annual, 2023-06-30) — Interest Expense: 21229743.00
BIOX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 21229743.00
BIOX cash_flow (annual, 2023-06-30) — Interest Paid Cff: -18046961.00
BIOX cash_flow (annual, 2023-06-30) — Interest Received Cfo: 5378413.00
BIOX balance_sheet (annual, 2023-06-30) — Inventories Adjustments Allowances: -2492499.00
BIOX balance_sheet (annual, 2023-06-30) — Inventory: 140573817.00
BIOX balance_sheet (annual, 2023-06-30) — Invested Capital: 542373732.00
BIOX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -25725670.00
BIOX balance_sheet (annual, 2023-06-30) — Investment Properties: 3589749.00
BIOX balance_sheet (annual, 2023-06-30) — Investmentin Financial Assets: 444909.00
BIOX balance_sheet (annual, 2023-06-30) — Investments And Advances: 39741719.00
BIOX cash_flow (annual, 2023-06-30) — Issuance Of Debt: 79817888.00
BIOX balance_sheet (annual, 2023-06-30) — Line Of Credit: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Loans Receivable: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 10030524.00
BIOX balance_sheet (annual, 2023-06-30) — Long Term Debt: 135884092.00
BIOX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 145914616.00
BIOX cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 79817888.00
BIOX cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -20600473.00
BIOX balance_sheet (annual, 2023-06-30) — Long Term Equity Investment: 39296810.00
BIOX balance_sheet (annual, 2023-06-30) — Long Term Provisions: 891769.00
BIOX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 19797849.00
BIOX balance_sheet (annual, 2023-06-30) — Minority Interest: 31646126.00
BIOX income_statement (annual, 2023-06-30) — Minority Interests: -1394723.00
BIOX cash_flow (annual, 2023-06-30) — Net Business Purchase And Sale: 4373265.00
BIOX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: -2996947.00
BIOX balance_sheet (annual, 2023-06-30) — Net Debt: 195394557.00
BIOX income_statement (annual, 2023-06-30) — Net Income: 18779876.00
BIOX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 18779876.00
BIOX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 20174599.00
BIOX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 18779876.00
BIOX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 18779876.00
BIOX cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: 20174599.00
BIOX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 20174599.00
BIOX cash_flow (annual, 2023-06-30) — Net Intangibles Purchase And Sale: -449673.00
BIOX income_statement (annual, 2023-06-30) — Net Interest Income: -23788085.00
BIOX cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: -7673103.00
BIOX cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: 59217415.00
BIOX cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: 59217415.00
BIOX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -23788085.00
BIOX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -5219507.00
BIOX balance_sheet (annual, 2023-06-30) — Net PPE: 81790410.00
BIOX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -11223112.00
BIOX cash_flow (annual, 2023-06-30) — Net Short Term Debt Issuance: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 12902593.00
BIOX balance_sheet (annual, 2023-06-30) — Non Current Accounts Receivable: 2332527.00
BIOX balance_sheet (annual, 2023-06-30) — Non Current Deferred Assets: 7312964.00
BIOX balance_sheet (annual, 2023-06-30) — Non Current Deferred Liabilities: 37843152.00
BIOX balance_sheet (annual, 2023-06-30) — Non Current Deferred Revenue: 2057805.00
BIOX balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Assets: 7312964.00
BIOX balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Liabilities: 35785347.00
BIOX balance_sheet (annual, 2023-06-30) — Non Current Note Receivables: 230000.00
BIOX income_statement (annual, 2023-06-30) — Normalized EBITDA: 72343609.00
BIOX income_statement (annual, 2023-06-30) — Normalized Income: 26981132.70
BIOX cash_flow (annual, 2023-06-30) — Operating Cash Flow: 2588792.00
BIOX cash_flow (annual, 2023-06-30) — Operating Gains Losses: -1140142.00
BIOX income_statement (annual, 2023-06-30) — Operating Income: 53227830.00
BIOX income_statement (annual, 2023-06-30) — Operating Revenue: 419446439.00
BIOX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 62796774.00
BIOX cash_flow (annual, 2023-06-30) — Other Cash Adjustment Outside Changein Cash: -101767.00
BIOX balance_sheet (annual, 2023-06-30) — Other Current Borrowings: 107639659.00
BIOX balance_sheet (annual, 2023-06-30) — Other Current Liabilities: 1415099.00
BIOX balance_sheet (annual, 2023-06-30) — Other Equity Interest: 15930703.00
BIOX income_statement (annual, 2023-06-30) — Other Gand A: 25911309.00
BIOX income_statement (annual, 2023-06-30) — Other Income Expense: -10333798.00
BIOX balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 173783956.00
BIOX balance_sheet (annual, 2023-06-30) — Other Inventories: 146842.00
BIOX balance_sheet (annual, 2023-06-30) — Other Investments: 274.00
BIOX cash_flow (annual, 2023-06-30) — Other Non Cash Items: 43002813.00
BIOX balance_sheet (annual, 2023-06-30) — Other Non Current Liabilities: 3578157.00
BIOX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 1084892.00
BIOX income_statement (annual, 2023-06-30) — Other Operating Expenses: 2067672.00
BIOX balance_sheet (annual, 2023-06-30) — Other Payable: 953301.00
BIOX balance_sheet (annual, 2023-06-30) — Other Properties: 21163192.00
BIOX balance_sheet (annual, 2023-06-30) — Other Receivables: 1857755.00
BIOX balance_sheet (annual, 2023-06-30) — Other Short Term Investments: 11922317.00
BIOX income_statement (annual, 2023-06-30) — Other Special Charges: -438502.00
BIOX income_statement (annual, 2023-06-30) — Other Taxes: 11533391.00
BIOX balance_sheet (annual, 2023-06-30) — Payables: 151316708.00
BIOX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 151316708.00
BIOX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 9606707.00
BIOX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 10956831.00
BIOX income_statement (annual, 2023-06-30) — Pretax Income: 19105947.00
BIOX cash_flow (annual, 2023-06-30) — Proceeds From Stock Option Exercised: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Properties: 36144792.00
BIOX cash_flow (annual, 2023-06-30) — Provisionand Write Offof Assets: 2615170.00
BIOX cash_flow (annual, 2023-06-30) — Purchase Of Business: 0.00
BIOX cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: -449673.00
BIOX cash_flow (annual, 2023-06-30) — Purchase Of Investment: -8990083.00
BIOX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -11360469.00
BIOX balance_sheet (annual, 2023-06-30) — Raw Materials: 26435346.00
BIOX balance_sheet (annual, 2023-06-30) — Receivables: 185319539.00
BIOX income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 232341016.00
BIOX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 19390601.00
BIOX cash_flow (annual, 2023-06-30) — Repayment Of Debt: -20600473.00
BIOX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -2996947.00
BIOX income_statement (annual, 2023-06-30) — Research And Development: 15345315.00
BIOX balance_sheet (annual, 2023-06-30) — Restricted Cash: 212703.00
BIOX income_statement (annual, 2023-06-30) — Restructuring And Mergern Acquisition: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Retained Earnings: -13903017.00
BIOX income_statement (annual, 2023-06-30) — Salaries And Wages: 41308387.00
BIOX cash_flow (annual, 2023-06-30) — Sale Of Business: 4373265.00
BIOX cash_flow (annual, 2023-06-30) — Sale Of Investment: 1316980.00
BIOX cash_flow (annual, 2023-06-30) — Sale Of PPE: 137357.00
BIOX income_statement (annual, 2023-06-30) — Selling And Marketing Expense: 15314531.00
BIOX income_statement (annual, 2023-06-30) — Selling General And Administration: 85540614.00
BIOX balance_sheet (annual, 2023-06-30) — Share Issued: 62796774.00
BIOX cash_flow (annual, 2023-06-30) — Short Term Debt Payments: 0.00
BIOX income_statement (annual, 2023-06-30) — Special Income Charges: -888883.00
BIOX cash_flow (annual, 2023-06-30) — Stock Based Compensation: 3415108.00
BIOX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 298849981.00
BIOX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 12902593.00
BIOX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: -4416061.30
BIOX income_statement (annual, 2023-06-30) — Tax Provision: -1068652.00
BIOX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.35
BIOX balance_sheet (annual, 2023-06-30) — Taxes Receivable: 15558662.00
BIOX cash_flow (annual, 2023-06-30) — Taxes Refund Paid: -4072347.00
BIOX balance_sheet (annual, 2023-06-30) — Total Assets: 818059158.00
BIOX balance_sheet (annual, 2023-06-30) — Total Capitalization: 434734073.00
BIOX balance_sheet (annual, 2023-06-30) — Total Debt: 257412974.00
BIOX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 330496107.00
BIOX income_statement (annual, 2023-06-30) — Total Expenses: 366218609.00
BIOX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 487563051.00
BIOX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 420944757.00
BIOX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 188850517.00
BIOX income_statement (annual, 2023-06-30) — Total Operating Income As Reported: 54183965.00
BIOX income_statement (annual, 2023-06-30) — Total Other Finance Cost: 2558342.00
BIOX balance_sheet (annual, 2023-06-30) — Total Tax Payable: 4070092.00
BIOX income_statement (annual, 2023-06-30) — Total Unusual Items: -12617318.00
BIOX income_statement (annual, 2023-06-30) — Total Unusual Items Excluding Goodwill: -12617318.00
BIOX balance_sheet (annual, 2023-06-30) — Tradeand Other Payables Non Current: 0.00
BIOX balance_sheet (annual, 2023-06-30) — Treasury Stock: 30553591.00
BIOX balance_sheet (annual, 2023-06-30) — Working Capital: 98401867.00
BIOX income_statement (annual, 2023-06-30) — Write Off: 1327385.00
BIOX income_statement (annual, 2024-06-30) — +Operating Expense: 138375354.00
BIOX income_statement (annual, 2024-06-30) — +Total Revenue: 464828548.00
BIOX balance_sheet (annual, 2024-06-30) — Accounts Payable: 161925095.00
BIOX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 207320974.00
BIOX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -9377845.00
BIOX balance_sheet (annual, 2024-06-30) — Additional Paid In Capital: 326859835.00
BIOX balance_sheet (annual, 2024-06-30) — Allowance For Doubtful Accounts Receivable: -9955904.00
BIOX income_statement (annual, 2024-06-30) — Amortization: 5950173.00
BIOX cash_flow (annual, 2024-06-30) — Amortization Cash Flow: 12113107.00
BIOX cash_flow (annual, 2024-06-30) — Amortization Of Intangibles: 12113107.00
BIOX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 5950173.00
BIOX balance_sheet (annual, 2024-06-30) — Available For Sale Securities: 634553.00
BIOX income_statement (annual, 2024-06-30) — Basic Average Shares: 62840129.00
BIOX income_statement (annual, 2024-06-30) — Basic EPS: 0.05
BIOX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 48129194.00
BIOX cash_flow (annual, 2024-06-30) — Capital Expenditure: -22782411.00
BIOX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -11855766.00
BIOX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 11284137.00
BIOX balance_sheet (annual, 2024-06-30) — Capital Stock: 6500.00
BIOX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 44473270.00
BIOX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 56168798.00
BIOX cash_flow (annual, 2024-06-30) — Cash Dividends Paid: 0.00
BIOX balance_sheet (annual, 2024-06-30) — Cash Equivalents: 19500222.00
BIOX balance_sheet (annual, 2024-06-30) — Cash Financial: 24973048.00
BIOX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: -10055867.00
BIOX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -28728255.00
BIOX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Operating Activities: 41716586.00
BIOX cash_flow (annual, 2024-06-30) — Change In Inventory: 14176656.00
BIOX cash_flow (annual, 2024-06-30) — Change In Other Working Capital: -18273188.00
BIOX cash_flow (annual, 2024-06-30) — Change In Payable: 14234092.00
BIOX cash_flow (annual, 2024-06-30) — Change In Payables And Accrued Expense: 14234092.00
BIOX cash_flow (annual, 2024-06-30) — Change In Receivables: -51648303.00
BIOX cash_flow (annual, 2024-06-30) — Change In Working Capital: -41510743.00
BIOX cash_flow (annual, 2024-06-30) — Changes In Account Receivables: -46681153.00
BIOX cash_flow (annual, 2024-06-30) — Changes In Cash: 2932464.00
BIOX balance_sheet (annual, 2024-06-30) — Common Stock: 6500.00
BIOX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 315297150.00
BIOX cash_flow (annual, 2024-06-30) — Common Stock Payments: -734388.00
BIOX balance_sheet (annual, 2024-06-30) — Construction In Progress: 12280422.00
BIOX income_statement (annual, 2024-06-30) — Cost Of Revenue: 282397796.00
BIOX balance_sheet (annual, 2024-06-30) — Current Assets: 408668037.00
BIOX balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 3122778.00
BIOX balance_sheet (annual, 2024-06-30) — Current Debt: 136747198.00
BIOX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 139869976.00
BIOX balance_sheet (annual, 2024-06-30) — Current Deferred Liabilities: 3923140.00
BIOX balance_sheet (annual, 2024-06-30) — Current Deferred Revenue: 3923140.00
BIOX balance_sheet (annual, 2024-06-30) — Current Liabilities: 329309095.00
BIOX cash_flow (annual, 2024-06-30) — Deferred Income Tax: 3778615.00
BIOX cash_flow (annual, 2024-06-30) — Deferred Tax: 3778615.00
BIOX cash_flow (annual, 2024-06-30) — Depreciation: 9182205.00
BIOX cash_flow (annual, 2024-06-30) — Depreciation Amortization Depletion: 21295312.00
BIOX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 10182888.00
BIOX cash_flow (annual, 2024-06-30) — Depreciation And Amortization: 21295312.00
BIOX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 10182888.00
BIOX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 4232715.00
BIOX income_statement (annual, 2024-06-30) — Diluted Average Shares: 63485432.00
BIOX income_statement (annual, 2024-06-30) — Diluted EPS: 0.05
BIOX income_statement (annual, 2024-06-30) — Diluted NI Availto Com Stockholders: 4275688.00
BIOX balance_sheet (annual, 2024-06-30) — Duefrom Related Parties Current: 207449.00
BIOX balance_sheet (annual, 2024-06-30) — Duefrom Related Parties Non Current: 15495543.00
BIOX balance_sheet (annual, 2024-06-30) — Dueto Related Parties Current: 37985.00
BIOX balance_sheet (annual, 2024-06-30) — Dueto Related Parties Non Current: 296455.00
BIOX income_statement (annual, 2024-06-30) — EBIT: 35192351.00
BIOX income_statement (annual, 2024-06-30) — EBITDA: 56487663.00
BIOX income_statement (annual, 2024-06-30) — Earnings From Equity Interest: 4049508.00
BIOX cash_flow (annual, 2024-06-30) — Earnings Losses From Equity Investments: -4049508.00
BIOX cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: -6556470.00
BIOX cash_flow (annual, 2024-06-30) — End Cash Position: 44473270.00
BIOX cash_flow (annual, 2024-06-30) — Financing Cash Flow: -10055867.00
BIOX balance_sheet (annual, 2024-06-30) — Finished Goods: 100504007.00
BIOX balance_sheet (annual, 2024-06-30) — Fixed Assets Revaluation Reserve: -160702.00
BIOX balance_sheet (annual, 2024-06-30) — Foreign Currency Translation Adjustments: 794189.00
BIOX cash_flow (annual, 2024-06-30) — Free Cash Flow: 18934175.00
BIOX cash_flow (annual, 2024-06-30) — Gain Loss On Sale Of PPE: -125464.00
BIOX income_statement (annual, 2024-06-30) — Gain On Sale Of Ppe: 0.00
BIOX income_statement (annual, 2024-06-30) — Gain On Sale Of Security: -9610972.00
BIOX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 633487.00
BIOX income_statement (annual, 2024-06-30) — General And Administrative Expense: 77449565.00
BIOX balance_sheet (annual, 2024-06-30) — Goodwill: 112163432.00
BIOX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 289056568.00
BIOX balance_sheet (annual, 2024-06-30) — Gross Accounts Receivable: 217276878.00
BIOX balance_sheet (annual, 2024-06-30) — Gross PPE: 95552875.00
BIOX income_statement (annual, 2024-06-30) — Gross Profit: 182430752.00
BIOX balance_sheet (annual, 2024-06-30) — Income Tax Payable: 4825271.00
BIOX income_statement (annual, 2024-06-30) — Insurance And Claims: 2117158.00
BIOX income_statement (annual, 2024-06-30) — Interest Expense: 24124753.00
BIOX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 24124753.00
BIOX cash_flow (annual, 2024-06-30) — Interest Paid Cff: -24724436.00
BIOX cash_flow (annual, 2024-06-30) — Interest Received Cfo: 2747398.00
BIOX balance_sheet (annual, 2024-06-30) — Inventories Adjustments Allowances: -3087563.00
BIOX balance_sheet (annual, 2024-06-30) — Inventory: 126223902.00
BIOX balance_sheet (annual, 2024-06-30) — Invested Capital: 574958916.00
BIOX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -28728255.00
BIOX balance_sheet (annual, 2024-06-30) — Investment Properties: 560783.00
BIOX balance_sheet (annual, 2024-06-30) — Investmentin Financial Assets: 634553.00
BIOX balance_sheet (annual, 2024-06-30) — Investments And Advances: 40420906.00
BIOX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 135818247.00
BIOX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 8161359.00
BIOX balance_sheet (annual, 2024-06-30) — Long Term Debt: 122914568.00
BIOX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 131075927.00
BIOX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 135818247.00
BIOX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -117493545.00
BIOX balance_sheet (annual, 2024-06-30) — Long Term Equity Investment: 39786353.00
BIOX balance_sheet (annual, 2024-06-30) — Long Term Provisions: 1255702.00
BIOX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 22614954.00
BIOX balance_sheet (annual, 2024-06-30) — Minority Interest: 36083702.00
BIOX income_statement (annual, 2024-06-30) — Minority Interests: -3013295.00
BIOX cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: 37508.00
BIOX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: -734388.00
BIOX balance_sheet (annual, 2024-06-30) — Net Debt: 215188496.00
BIOX income_statement (annual, 2024-06-30) — Net Income: 4275688.00
BIOX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: 4275688.00
BIOX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: 7288983.00
BIOX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: 4275688.00
BIOX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: 4275688.00
BIOX cash_flow (annual, 2024-06-30) — Net Income From Continuing Operations: 7288983.00
BIOX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: 7288983.00
BIOX cash_flow (annual, 2024-06-30) — Net Intangibles Purchase And Sale: -1137071.00
BIOX income_statement (annual, 2024-06-30) — Net Interest Income: -26871698.00
BIOX cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: -6320078.00
BIOX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 18324702.00
BIOX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 18324702.00
BIOX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -26871698.00
BIOX cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -2921745.00
BIOX balance_sheet (annual, 2024-06-30) — Net PPE: 86175030.00
BIOX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -9452848.00
BIOX cash_flow (annual, 2024-06-30) — Net Short Term Debt Issuance: 0.00
BIOX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 26240582.00
BIOX balance_sheet (annual, 2024-06-30) — Non Current Accounts Receivable: 17738010.00
BIOX balance_sheet (annual, 2024-06-30) — Non Current Deferred Assets: 9698860.00
BIOX balance_sheet (annual, 2024-06-30) — Non Current Deferred Liabilities: 36920929.00
BIOX balance_sheet (annual, 2024-06-30) — Non Current Deferred Revenue: 1925138.00
BIOX balance_sheet (annual, 2024-06-30) — Non Current Deferred Taxes Assets: 9698860.00
BIOX balance_sheet (annual, 2024-06-30) — Non Current Deferred Taxes Liabilities: 34995791.00
BIOX balance_sheet (annual, 2024-06-30) — Non Current Note Receivables: 230000.00
BIOX income_statement (annual, 2024-06-30) — Normalized EBITDA: 64122391.00
BIOX income_statement (annual, 2024-06-30) — Normalized Income: 9303825.32
BIOX cash_flow (annual, 2024-06-30) — Operating Cash Flow: 41716586.00
BIOX cash_flow (annual, 2024-06-30) — Operating Gains Losses: -4174972.00
BIOX income_statement (annual, 2024-06-30) — Operating Income: 44055398.00
BIOX income_statement (annual, 2024-06-30) — Operating Revenue: 464828548.00
BIOX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 60590467.00
BIOX cash_flow (annual, 2024-06-30) — Other Cash Adjustment Outside Changein Cash: -31918.00
BIOX balance_sheet (annual, 2024-06-30) — Other Current Borrowings: 136747198.00
BIOX balance_sheet (annual, 2024-06-30) — Other Current Liabilities: 4617281.00
BIOX balance_sheet (annual, 2024-06-30) — Other Equity Interest: 28712636.00
BIOX income_statement (annual, 2024-06-30) — Other Gand A: 24566196.00
BIOX income_statement (annual, 2024-06-30) — Other Income Expense: -6116102.00
BIOX balance_sheet (annual, 2024-06-30) — Other Intangible Assets: 176893136.00
BIOX balance_sheet (annual, 2024-06-30) — Other Inventories: 294134.00
BIOX cash_flow (annual, 2024-06-30) — Other Non Cash Items: 37303338.00
BIOX balance_sheet (annual, 2024-06-30) — Other Non Current Liabilities: 2309234.00
BIOX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: -2530882.00
BIOX income_statement (annual, 2024-06-30) — Other Operating Expenses: 2558352.00
BIOX balance_sheet (annual, 2024-06-30) — Other Payable: 1121839.00
BIOX balance_sheet (annual, 2024-06-30) — Other Properties: 20979597.00
BIOX balance_sheet (annual, 2024-06-30) — Other Receivables: 2829489.00
BIOX balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 11695528.00
BIOX income_statement (annual, 2024-06-30) — Other Special Charges: -1697345.00
BIOX income_statement (annual, 2024-06-30) — Other Taxes: 14184503.00
BIOX balance_sheet (annual, 2024-06-30) — Payables: 173557740.00
BIOX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 173557740.00
BIOX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 7340958.00
BIOX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 10242075.00
BIOX income_statement (annual, 2024-06-30) — Pretax Income: 11067598.00
BIOX balance_sheet (annual, 2024-06-30) — Properties: 39677902.00
BIOX cash_flow (annual, 2024-06-30) — Provisionand Write Offof Assets: 1707069.00
BIOX cash_flow (annual, 2024-06-30) — Purchase Of Intangibles: -1137071.00
BIOX cash_flow (annual, 2024-06-30) — Purchase Of Investment: -7208218.00
BIOX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -9789574.00
BIOX balance_sheet (annual, 2024-06-30) — Raw Materials: 28513324.00
BIOX balance_sheet (annual, 2024-06-30) — Receivables: 216033262.00
BIOX income_statement (annual, 2024-06-30) — Reconciled Cost Of Revenue: 271285372.00
BIOX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 21295312.00
BIOX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -117493545.00
BIOX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -734388.00
BIOX income_statement (annual, 2024-06-30) — Research And Development: 17183041.00
BIOX balance_sheet (annual, 2024-06-30) — Restricted Cash: 0.00
BIOX income_statement (annual, 2024-06-30) — Restructuring And Mergern Acquisition: -1032327.00
BIOX balance_sheet (annual, 2024-06-30) — Retained Earnings: -9627329.00
BIOX income_statement (annual, 2024-06-30) — Salaries And Wages: 50766211.00
BIOX cash_flow (annual, 2024-06-30) — Sale Of Business: 37508.00
BIOX cash_flow (annual, 2024-06-30) — Sale Of Investment: 888140.00
BIOX cash_flow (annual, 2024-06-30) — Sale Of PPE: 336726.00
BIOX income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 16817005.00
BIOX income_statement (annual, 2024-06-30) — Selling General And Administration: 94266570.00
BIOX balance_sheet (annual, 2024-06-30) — Share Issued: 62848483.00
BIOX cash_flow (annual, 2024-06-30) — Short Term Debt Payments: 0.00
BIOX income_statement (annual, 2024-06-30) — Special Income Charges: 1976244.00
BIOX cash_flow (annual, 2024-06-30) — Stock Based Compensation: 14134885.00
BIOX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 315297150.00
BIOX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 26240582.00
BIOX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: -2606590.68
BIOX income_statement (annual, 2024-06-30) — Tax Provision: 3778615.00
BIOX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.34
BIOX balance_sheet (annual, 2024-06-30) — Taxes Receivable: 5675350.00
BIOX cash_flow (annual, 2024-06-30) — Taxes Refund Paid: -853299.00
BIOX balance_sheet (annual, 2024-06-30) — Total Assets: 852548194.00
BIOX balance_sheet (annual, 2024-06-30) — Total Capitalization: 438211718.00
BIOX balance_sheet (annual, 2024-06-30) — Total Debt: 270945903.00
BIOX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 351380852.00
BIOX income_statement (annual, 2024-06-30) — Total Expenses: 420773150.00
BIOX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 501167342.00
BIOX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 443880157.00
BIOX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 171858247.00
BIOX income_statement (annual, 2024-06-30) — Total Operating Income As Reported: 45852923.00
BIOX income_statement (annual, 2024-06-30) — Total Other Finance Cost: 2746945.00
BIOX balance_sheet (annual, 2024-06-30) — Total Tax Payable: 10472821.00
BIOX income_statement (annual, 2024-06-30) — Total Unusual Items: -7634728.00
BIOX income_statement (annual, 2024-06-30) — Total Unusual Items Excluding Goodwill: -7634728.00
BIOX balance_sheet (annual, 2024-06-30) — Tradeand Other Payables Non Current: 0.00
BIOX balance_sheet (annual, 2024-06-30) — Treasury Shares Number: 2258016.00
BIOX balance_sheet (annual, 2024-06-30) — Treasury Stock: 31287979.00
BIOX balance_sheet (annual, 2024-06-30) — Working Capital: 79358942.00
BIOX income_statement (annual, 2024-06-30) — Write Off: 753428.00
BIOX balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 558625.00
BIOX cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
BIOX cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
BIOX balance_sheet (quarterly, 2024-09-30) — Other Current Assets: -100000.00
BIOX balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: -200000.00
BIOX cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
BIOX cash_flow (quarterly, 2024-09-30) — Taxes Refund Paid: 0.00
BIOX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -11453537.00
BIOX balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 326922890.00
BIOX balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -8706185.00
BIOX income_statement (quarterly, 2024-12-31) — Amortization: 334208.00
BIOX cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: -661898.00
BIOX cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: -661898.00
BIOX income_statement (quarterly, 2024-12-31) — Amortization Of Intangibles Income Statement: 334208.00
BIOX balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 817544.00
BIOX cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 32278411.00
BIOX cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -3376811.00
BIOX cash_flow (quarterly, 2024-12-31) — Capital Expenditure Reported: -1782060.00
BIOX balance_sheet (quarterly, 2024-12-31) — Capital Stock: 6500.00
BIOX cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
BIOX balance_sheet (quarterly, 2024-12-31) — Cash Financial: 29176741.00
BIOX cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3834570.00
BIOX cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -2660179.00
BIOX cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -5562034.00
BIOX cash_flow (quarterly, 2024-12-31) — Change In Inventory: 13256427.00
BIOX cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -397110.00
BIOX cash_flow (quarterly, 2024-12-31) — Change In Payable: -13929929.00
BIOX cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -13929929.00
BIOX cash_flow (quarterly, 2024-12-31) — Change In Receivables: -29649830.00
BIOX cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -30720442.00
BIOX cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -35878300.00
BIOX cash_flow (quarterly, 2024-12-31) — Changes In Cash: -4256635.00
BIOX balance_sheet (quarterly, 2024-12-31) — Common Stock: 6500.00
BIOX cash_flow (quarterly, 2024-12-31) — Common Stock Payments: -926899.00
BIOX balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 15646161.00
BIOX cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 1010883.00
BIOX cash_flow (quarterly, 2024-12-31) — Deferred Tax: 1010883.00
BIOX cash_flow (quarterly, 2024-12-31) — Depreciation: 1886550.00
BIOX cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 1224652.00
BIOX income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 1377230.00
BIOX cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 1224652.00
BIOX income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 1377230.00
BIOX income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 1043022.00
BIOX balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 407898.00
BIOX balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Non Current: 16184334.00
BIOX balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 49646.00
BIOX cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: -360155.00
BIOX cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 1152984.00
BIOX cash_flow (quarterly, 2024-12-31) — End Cash Position: 25031216.00
BIOX cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 6485821.00
BIOX balance_sheet (quarterly, 2024-12-31) — Finished Goods: 78351668.00
BIOX balance_sheet (quarterly, 2024-12-31) — Fixed Assets Revaluation Reserve: -160702.00
BIOX balance_sheet (quarterly, 2024-12-31) — Foreign Currency Translation Adjustments: 998862.00
BIOX cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -8733999.00
BIOX cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 179362.00
BIOX income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
BIOX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 838160.00
BIOX income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 14239046.00
BIOX balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 235164613.00
BIOX income_statement (quarterly, 2024-12-31) — Insurance And Claims: 554717.00
BIOX cash_flow (quarterly, 2024-12-31) — Interest Paid Cff: -7789539.00
BIOX cash_flow (quarterly, 2024-12-31) — Interest Received Cfo: 3143693.00
BIOX balance_sheet (quarterly, 2024-12-31) — Inventories Adjustments Allowances: -3462573.00
BIOX cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -5385268.00
BIOX balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 817544.00
BIOX cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 38583622.00
BIOX cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 38583622.00
BIOX cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -24813782.00
BIOX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 20301458.00
BIOX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -926899.00
BIOX income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: -6058318.00
BIOX cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 9087271.00
BIOX cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -77271.00
BIOX cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 897887.00
BIOX cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 13769840.00
BIOX cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 13769840.00
BIOX cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -1218832.00
BIOX cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -1698735.00
BIOX balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 230000.00
BIOX cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -5357188.00
BIOX cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -180793.00
BIOX cash_flow (quarterly, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -4143544.00
BIOX balance_sheet (quarterly, 2024-12-31) — Other Current Assets: -100000.00
BIOX balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 30108587.00
BIOX income_statement (quarterly, 2024-12-31) — Other Gand A: 4465693.00
BIOX cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 7994526.00
BIOX income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 549863.00
BIOX balance_sheet (quarterly, 2024-12-31) — Other Payable: 195485.00
BIOX income_statement (quarterly, 2024-12-31) — Other Taxes: 3999151.00
BIOX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 5525881.00
BIOX balance_sheet (quarterly, 2024-12-31) — Properties: 38953624.00
BIOX cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 1480377.00
BIOX cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -77271.00
BIOX cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -2917043.00
BIOX cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -1517480.00
BIOX balance_sheet (quarterly, 2024-12-31) — Raw Materials: 26920394.00
BIOX income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 1224652.00
BIOX cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -24813782.00
BIOX cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -926899.00
BIOX income_statement (quarterly, 2024-12-31) — Research And Development: 1968597.00
BIOX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -15853056.00
BIOX income_statement (quarterly, 2024-12-31) — Salaries And Wages: 9218636.00
BIOX cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 3814930.00
BIOX cash_flow (quarterly, 2024-12-31) — Sale Of PPE: -181255.00
BIOX income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 3258271.00
BIOX income_statement (quarterly, 2024-12-31) — Selling General And Administration: 17497317.00
BIOX income_statement (quarterly, 2024-12-31) — Special Income Charges: -1738911.00
BIOX cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 1397799.00